Clinical trial NCT03678324: Pre-Clinical White Matter Changes and Associated Connectivity Effects in Fabry Disease
Official title: Pre-Clinical White Matter Changes and Associated Connectivity Effects in Fabry Disease
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Fabry Disease
Keywords: fabry
MRI (Magnetic resonance imaging)
Fabry brain lesions
Lead sponsor: University of Utah
Sponsor class: OTHER
Collaborators: name: Genzyme, a Sanofi Company
First posted: 2018-09-19
Enrollment: 40
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: NA
Intervention model: SINGLE_GROUP
Intervention model description: 20 patients with Fabry and 20 unaffected
Primary purpose: BASIC_SCIENCE

Brief summary: The purpose of this research project is:

* to use an advanced quantitative MRI technique (FBFI) to detect and quantify brain lesion in patients with FD
* to use fMRI to identify altered brain function
* to use FBFI and fMRI together to map altered connectivity in response to brain lesions

Detailed description: Fabry disease (FD) is a lysosomal storage disease caused by a deficiency in an enzyme that degrades components of the outer cell wall. A deficiency of this enzyme in humans has been associated with stroke. In males with FD, 6.9% have a stroke by 39 years of age. In females with FD, 4.3% have a stroke by 46 years of age.

Magnetic resonance imaging (MRI) is the main tool for studying stroke in FD. Importantly, MRI has identified other types of lesions in the brain beyond that caused by stroke. These additional lesions may herald stroke or be a different manifestation of FD in the brain. These lesions are seen in \>50% of men and women with FD.

Diffusion-based imaging MRI has been the leading approach for studying these lesions in FD. However, these lesions that appear to be specific to FD are difficult to quantify, analyze, and interpret using this and other current MRI methods. The Investigators would like to use a form of MRI called fast bound-pool fraction imaging (FBFI), which is a technique better suited to capture and quantify these lesions, to study these lesions in patients with FD. In parallel, the investigators would like to use functional MRI (fMRI) to study how these lesions alter brain function and connectivity in FD. The combination of these techniques (FBFI + fMRI) will also provide us the opportunity to study brain plasticity in response to injury as Fabry disease is slowly progressive over decades allowing the brain to remodel connections to maintain function.

Eligibility criteria: Fabry Cohort

Inclusion Criteria:

* Have Fabry Disease
* Must be 18yrs or older

Exclusion Criteria:

* Subjects who are claustrophobic
* have metal implants
* Cannot pass the MRI safety screening questionnaire.

Unaffected Controls

Inclusion Criteria:

* Must be 18yrs or older
* unaffected with Fabry Disease
* considered healthy with no previous history of stroke, multiple sclerosis, diabetes mellitus, or other neurologic disease.

Exclusion Criteria:

* Subjects who are claustrophobic
* have metal implants
* Cannot pass the MRI safety screening questionnaire.

Primary outcomes:
measure: FBFI MRI using advanced MRI technique
timeFrame: 6 months after enrollment closes
measure: Identify difference between patients with Fabry disease and healthy controls in brain function as measured and quantified by functional MRI
timeFrame: 6 months after enrollment closes
measure: use FBFI and fMRI to map
timeFrame: 6 months after enrollment closes
Secondary outcomes:
Other outcomes:
Locations:
city: Salt Lake City
country: United States
facility: University of Utah
state: Utah
Study officials:
References: